Navigation Links
Amgen Acquires Filgrastim Franchise Rights From Roche In 100 Markets
Date:10/22/2013

THOUSAND OAKS, Calif., Oct. 22, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it has entered into a definitive agreement with F. Hoffmann-La Roche ("Roche") to acquire Roche's rights to filgrastim and pegfilgrastim in approximately 100 markets, effective Jan. 1, 2014.

Roche has held the rights to filgrastim and pegfilgrastim under license from Kirin-Amgen, Inc. (a joint venture between Amgen and Kirin Holdings Co. Limited, of Japan) in Eastern Europe, Latin America, Asia, the Middle East and Africa since 1989. The franchise generated approximately $200 million in sales in these territories in 2012.

Filgrastim and pegfilgrastim are white blood cell boosting therapeutics used to reduce the risk of infection in patients receiving chemotherapy.  They are marketed by Amgen in the United States and Europe under the trade names NEUPOGEN® and Neulasta®, respectively.

"This agreement will enable Amgen to reach more patients around the world with two of our innovative medicines," said Robert A. Bradway, chairman and chief executive officer of Amgen. "The transaction will also allow us to build experience and capacity in countries that will be important in accelerating future growth of Amgen's pipeline products."

Amgen anticipates this deal will be accretive starting in 2014.

Amgen will begin distributing and selling product as soon as practical in countries where the Company has an existing commercial presence. In countries where Amgen does not have a presence, Roche or its distributors will continue to sell and
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
2. Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Onyx
3. Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil
4. Amgen To Participate At Citis 8th Annual Biotech Conference
5. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
6. Amgen to Highlight New Data at Upcoming ESC Congress 2013
7. Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders
8. Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
9. Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc.
10. Amgens Second Quarter 2013 Revenues Increased 5 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 3 Percent To $1.89
11. Amgen Announces Webcast of 2013 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... et SAN DIEGO , ... Ltd. (ci-après désignée Daiichi Sankyo) (TSE : 4568) et ... la conclusion d,un accord de fusion définitif en ... totalité des actions ordinaires en circulation d,Ambit Biosciences ... le biais d,une offre publique d,achat qui sera ...
(Date:9/29/2014)... Pharmacists have an important role in ... good clinical trials practices. The Hematology/Oncology Pharmacy Association ... Practice Standards, the first of its kind that ... pharmacists and institutions that conduct clinical trials. The ... the critical role of the pharmacist in the ...
(Date:9/29/2014)... -- Bob Pack, who lost his two young children to ... Association to immediately cease airing a television ad from ... News called "shamelessly deceptive" and of which the LA ... about the measure is wrong." The ... doctors check California,s existing statewide ...
Breaking Medicine Technology:Daiichi Sankyo va acquérir Ambit Biosciences 2Daiichi Sankyo va acquérir Ambit Biosciences 3Daiichi Sankyo va acquérir Ambit Biosciences 4Daiichi Sankyo va acquérir Ambit Biosciences 5Daiichi Sankyo va acquérir Ambit Biosciences 6Daiichi Sankyo va acquérir Ambit Biosciences 7Daiichi Sankyo va acquérir Ambit Biosciences 8Daiichi Sankyo va acquérir Ambit Biosciences 9HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 2HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 2Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 4Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 5
... Cumberland Pharmaceuticals Inc.(Nasdaq: CPIX ) today announced ... review of the supplemental new drug application (sNDA) for the ... non-acetaminophen acute liver failure. The review has been extended by ... Act (PDUFA) goal date in December 2010. ...
... Aug. 20 Environmental Tectonics Corporation,s (OTC Bulletin ... ,Company") Biomedical Systems, a worldwide leader in the ... confirmed that it has received FDA 510-k clearance ... for "Operating System for Control And Recording." This ...
Cached Medicine Technology:Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 2Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 3ETC Biomedical Systems Offers New FDA Approved Hyperbaric Oxygen Therapy (HBOT) Medical Device 2ETC Biomedical Systems Offers New FDA Approved Hyperbaric Oxygen Therapy (HBOT) Medical Device 3ETC Biomedical Systems Offers New FDA Approved Hyperbaric Oxygen Therapy (HBOT) Medical Device 4
(Date:9/30/2014)... 2014 Bibliomotion is proud to ... Leadership for the Complex Social Age by Frank Guglielmo ... In the book, the authors apply their leadership coaching experience ... view the conversations, actions, and behaviors that leaders must adopt ... Click here to read a review of The Social ...
(Date:9/30/2014)... Pyramid Analytics, worldwide leader in ... Department of Veterans Affairs has selected Pyramid ... User Business Intelligence platform. This partnership will enable ... by enabling more than 30,000 users with insights ... analytics and reporting capabilities. , The strategic selection ...
(Date:9/30/2014)... RBS Reputation Management is reported to have started a ... , The service name may surprise as well as confuse ... odd name, a management professional said, “This may be your ... have named the service ‘Remove Your Name’ because it would ... all those posts which light their name in bad sense.” ...
(Date:9/30/2014)... Toronto, Ontario, Canada (PRWEB) September 30, 2014 ... of diagnostic imaging services based in San Juan, ... and automate their workflows. , Nivia Souffront, ... impact to their facility. “We are excited to ... able to provide better patient care and physician ...
(Date:9/30/2014)... A trailblazer at heart, Dr. Scott Katzman stays versed in ... spine repairs. His newest appreciation has been for the ... he has implanted the Mobi-C Artificial Disc by ... mimic normal human disc motion. Dr. Katzman goes on to ... an exceptional replacement device for failing fusions. Patients that have ...
Breaking Medicine News(10 mins):Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 3Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 4Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 5Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 6Health News:U.S. Department of Veterans Affairs Takes Its Analytic Capabilities to the Next Level with BI Office from Pyramid Analytics 2Health News:RBS Reputation Management Announces A New Service ‘Remove Your Name’ 2Health News:Signet Puerto Rico Leverages PowerServer RIS/PACS/PM™ to Improve Patient Care, Cut Costs 2
... Hospital surgeons found that a carefully-selected surgical care check ... nearly 50 percent. Smoking cessation at least ... to skin closure, and using clippers over razors to shave ... reduced infection rates, according to the study published in the ...
... TUESDAY, Oct. 25 (HealthDay News) -- The most widely used ... percent effective in healthy adults, new research indicates. That ... about 90 percent of flu shots in this country, according ... The Lancet Infectious Diseases . The less common live ...
... just for making freckles and tans. Melanocytes absorb ultraviolet light, ... They also are the cells that go haywire in melanoma, ... albinism. Naturally, researchers would love to study melanocytes in ... skin don,t grow very well in the lab. Now, researchers ...
... the more than 10,000 substances that may be added ... a trade association without review by the U.S. Food ... by the Pew Health Group. , The report, published ... Food Science and Food Safety , illustrates potential problems ...
... Stanford, CA -- Calling for more rapid innovation in ... program of the Thiel Foundation, Breakout Labs. Speaking ... Association of Stanford Entrepreneurial Students, Thiel announced that Breakout ... way early-stage science and technology research is funded by ...
... in the Department of Radiation Oncology at Thomas Jefferson ... named an "Educator of the Year" by the Association ... the annual Educator of the Year Award to recognize ... from all radiation oncology programs were given the opportunity ...
Cached Medicine News:Health News:Thomas Jefferson University Hospital cuts Whipple procedure wound infections in half with new measures 2Health News:Flu Vaccine Isn't Foolproof 2Health News:Flu Vaccine Isn't Foolproof 3Health News:Lab-made skin cells will aid transplantation, cancer, drug discovery research 2Health News:Food chemical regulations rely heavily on industry self-policing and lack transparency 2Health News:Peter Thiel announces Breakout Labs to energize innovation 2Health News:Jefferson physician named an 'Educator of the Year' by the Assocociation of Residents in Radiation Oncology 2
... to add individual components for individual indications. ... indications. Made of an innovative composite plastic ... only much lighter. This means it's easier ... comfortable for the patient. ,Comes pre-assembled, packaged ...
... (iopamidol injection) is a safe and effective ... clinical experience since 1986. Worldwide, more ... been administered. Indicated for a wide ... flexibility by providing a wide range of ...
... agent FDA-approved for administration by power injector, ... contrast media for MR imaging of the ... convenient packaging options for just the right ... delivery. You can trust OptiMARK® for ...
... contrast agent approved for sale in the ... the Amersham Health portfolio to include an ... aids in the detection, localization, characterization, and ... within minutes of injection, and additional scans ...
Medicine Products: